adenocarcinoma

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Lung Tumors, Carcinoma Non-small-cell Lung, Adenocarcinoma Trial in Rochester (Multifocal Lung Adenocarcinoma)

Active, not recruiting
  • Lung Neoplasms
  • +2 more
  • Multifocal Lung Adenocarcinoma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 3, 2021

Isolating and Testing Circulating Tumor DNA and Soluble Immune

Completed
  • Lung Cancer
  • +10 more
    • Rochester, Minnesota
      Mayo Clinic
    Jul 19, 2021

    NSCLC, Adenocarcinoma Trial in Worldwide (Pemetrexed, BIBW 2992, Cisplatin)

    Completed
    • Carcinoma, Non-Small-Cell Lung
    • Adenocarcinoma
    • Fayetteville, Arkansas
    • +132 more
    Mar 9, 2018

    Isolate and Test Circulating Tumor Cells Using ClearCell® FX EP+

    Completed
    • Lung Cancer
    • +10 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Mar 20, 2018

      Prostatic Tumors, Adenocarcinoma Trial in Rochester (Robotic Radical Prostatectomy, Open Radical Prostatectomy)

      Terminated
      • Prostatic Neoplasms
      • Adenocarcinoma
      • Robotic Radical Prostatectomy
      • Open Radical Prostatectomy
      • Rochester, Minnesota
        Mayo Clinic
      May 30, 2014

      Adenocarcinoma, Non-Small-Cell Lung Carcinoma, Lung Tumors Trial in Canada, United States (Motexafin Gadolinium)

      Completed
      • Adenocarcinoma
      • +2 more
      • Motexafin Gadolinium
      • Fountain Valley, California
      • +15 more
      Aug 19, 2008

      Prostate Cancer, Adenocarcinoma Trial in Worldwide (Atrasentan)

      Completed
      • Prostate Cancer
      • Adenocarcinoma
      • Marina Del Rey, California
      • +14 more
      Nov 28, 2007